NMT Medical, Inc. (NASDAQ: NMTI), a leader in the emerging field of structural heart repair, is focused on designing, developing, manufacturing and marketing proprietary implant technologies that allow interventional cardiologists to treat certain structural heart disease through minimally invasive, catheter-based procedures. By working with qualified physicians, the company has provided minimally invasive treatment for an array of cardiac defects for more than two decades. For further information, visit the Company’s web site at www.nmtmedical.com.
- 17 years ago
QualityStocks
NMT Medical, Inc. (NASDAQ: NMTI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Adjourns Special Meeting Due to Lack of Quorum
TransCode Therapeutics (NASDAQ: RNAZ) announced that its April 21 special meeting has been adjourned to…
-
Soligenix Inc. (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin Cancer
The global rare disease treatment market was estimated at $195.2 billion in 2024 and is…
-
Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Is ‘One to Watch’
High-Grade Copper Opportunity: 100% ownership of the New Craigmont Project, one of British Columbia’s most promising…